Literature DB >> 9464265

Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B.

I K Jang1, Z H Lee, Y J Kim, S H Kim, B S Kwon.   

Abstract

Human 4-1BB (CD137), a member of the tumor necrosis factor receptor (TNFR) superfamily, costimulates T cell activation. No apparent intrinsic kinase activity is seen with 4-1BB, which suggests that 4-1BB-associated molecules may be involved in 4-1BB-mediated signal transduction. We found that tumor necrosis factor receptor-associated factor (TRAF) 1, TRAF2, and TRAF3, all interacted with the cytoplasmic domain of 4-1BB. Mutation analysis showed that TRAF1, TRAF2, and TRAF3 were associated with one of two runs of acidic residues found in the cytoplasmic domain of 4-1BB. In addition, 4-1BB cross-linking with TCR signal in Jurkat cells and overexpression of 4-1BB in 293 cells were able to induce activation of the nuclear factor-kappa B (NF-kappa B). 4-1BB-mediated NF-kappa B activation was inhibited by a dominant negative-TRAF2 or -NF-kappa B-inducing kinase (NIK). These data suggest that 4-1BB functions may be mediated by NF-kappa B activation, which requires a TRAF2/NIK pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9464265     DOI: 10.1006/bbrc.1997.8016

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  43 in total

1.  Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells.

Authors:  Ann J McPherson; Laura M Snell; Tak W Mak; Tania H Watts
Journal:  J Biol Chem       Date:  2012-05-08       Impact factor: 5.157

Review 2.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Authors:  Joanne M Hildebrand; Zuoan Yi; Claire M Buchta; Jayakumar Poovassery; Laura L Stunz; Gail A Bishop
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

3.  Differentiated agonistic antibody targeting CD137 eradicates large tumors without hepatotoxicity.

Authors:  Ugur Eskiocak; Wilson Guzman; Benjamin Wolf; Christine Cummings; Lauren Milling; Hsin-Jung Wu; Michael Ophir; Conner Lambden; Pearl Bakhru; Dana C Gilmore; Samantha Ottinger; Lucy Liu; William K McConaughy; Sunny Q He; Chao Wang; Cheuk Lun Leung; Jason Lajoie; William F Carson; Nora Zizlsperger; Michael M Schmidt; Ana C Anderson; Piotr Bobrowicz; Thomas J Schuetz; Robert Tighe
Journal:  JCI Insight       Date:  2020-03-12

Review 4.  Roles of TRAF3 in T cells: many surprises.

Authors:  Zuoan Yi; Alicia M Wallis; Gail A Bishop
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  4-1BB enhancement of CAR T function requires NF-κB and TRAFs.

Authors:  Gongbo Li; Justin C Boucher; Hiroshi Kotani; Kyungho Park; Yongliang Zhang; Bishwas Shrestha; Xuefeng Wang; Lawrence Guan; Nolan Beatty; Daniel Abate-Daga; Marco L Davila
Journal:  JCI Insight       Date:  2018-09-20

6.  THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells.

Authors:  Chuang Sun; Peishun Shou; Hongwei Du; Koichi Hirabayashi; Yuhui Chen; Laura E Herring; Sarah Ahn; Yang Xu; Kyogo Suzuki; Guangming Li; Ourania Tsahouridis; Lishan Su; Barbara Savoldo; Gianpietro Dotti
Journal:  Cancer Cell       Date:  2020-01-30       Impact factor: 31.743

7.  CD137 Plays Both Pathogenic and Protective Roles in Type 1 Diabetes Development in NOD Mice.

Authors:  Matthew H Forsberg; Ashley E Ciecko; Kyle J Bednar; Arata Itoh; Kritika Kachapati; William M Ridgway; Yi-Guang Chen
Journal:  J Immunol       Date:  2017-03-31       Impact factor: 5.422

Review 8.  The pharmacology of second-generation chimeric antigen receptors.

Authors:  Sjoukje J C van der Stegen; Mohamad Hamieh; Michel Sadelain
Journal:  Nat Rev Drug Discov       Date:  2015-07       Impact factor: 84.694

Review 9.  TNF superfamily: costimulation and clinical applications.

Authors:  Dass S Vinay; Byoung S Kwon
Journal:  Cell Biol Int       Date:  2009-02-20       Impact factor: 3.612

Review 10.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.